Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smartphone app ease ADHD and anxiety in kids?

NCT ID NCT05741307

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 32 times

Summary

This study tested whether a self-hypnosis smartphone app called Hypnotidoo could help reduce inattention and anxiety in children aged 7 to 12 with ADHD who are already taking medication. The app offers short, screenless audio sessions focused on relaxation and coping. Researchers compared children who used the app for 6 weeks alongside their usual treatment to those who only received usual treatment. The goal was to see if the app could provide extra support for common ADHD symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hôpital Necker-Enfants Malades

    Paris, 75015, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

self-hypnosis smartphone application (Hypnotidoo)

What this could lead to

If it works, this could offer a simple, non-drug tool to help children with ADHD manage inattention and anxiety at home.

What could go wrong

This is a small, early-stage study with only 49 participants. The app may not provide meaningful improvement over standard care, and results rely on questionnaires, not objective measures.

Conditions

The condition(s) this trial relates to.

anxiety disorder attention deficit hyperactivity disorder, inattentive type

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.